Sentinel Lymph Node Mapping in the Management of High Risk Malignant Melanoma

References

• Reintgen D., Balch C. M., Kirkwood J., Ross M. Recent advances in the care of the patient with malignant melanoma. Ann Surg, 1997, 1: 1-14.
   Web of Science ®Google Scholar
• Balch C. M., Soong S. J., Murad T. M., Ingalls A. L., Madden W. A. A multifactorial analysis of melanoma. III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg, 1991, 193: 77-85.
   Google Scholar
• Breslow A. Thickness, cross-sectional areas and depth of melanoma in the prognosis of cutaneous melanoma. Ann Surg, 1970, 72: 902-8.
   Web of Science ®Google Scholar
• Balch C. M., Soong S. J., Milton G. W. et al. A comparision of prognostic factors and surgical results in 1786 patients with localised (stage I) melanoma treated in Alabama. USA and New South Wales, Australia. Ann Surg, 1982, 196: 677-84.
   PubMed Web of Science ®Google Scholar
• Veronesi U., Adamus J., Bandiera D. C. et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med, 1977, 297: 627-30.
   PubMed Web of Science ®Google Scholar
• Sim F. H., Taylor W. F., Ivins J. C. et al. A prospective randomised study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Cancer, 1978, 41: 948-56.
   PubMed Web of Science ®Google Scholar
• Milton G. W., Shaw H. M., McCarthy W. H. et al. Prophylactic lymph node dissection in stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg, 1982, 69: 108-11.
   PubMed Web of Science ®Google Scholar
• Reintgen D. S., Cox E. B., McCarthy K. M. Jr. et al. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg, 1983, 198: 379-85.
   PubMed Web of Science ®Google Scholar
• Slingluff C. L., Stidham K. R., Ricci W. M., Stanley W. E., Seigler H. F. Surgical management of regional lymph nodes in patients with melanoma. Ann Surg, 1994, 219: 120-30.
   PubMed Web of Science ®Google Scholar
• Morton D. L., Wen D. R., Cochran A. J. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992, 1: 247-59.
   Google Scholar
• Morton D. L., Wen D. R., Cochran A. J. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy or «watch and wait». Surg Oncol Clin North Am, 1992, 1: 247-59.
   Google Scholar
• Ross M., Reintgen D. S., Balch C. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol, 1993, 9: 219-23.
   PubMed Web of Science ®Google Scholar
• Reintgen D. S. Melanoma nodal metastases. Surg Oncol Clin, 1996, 5: 105-20.
   PubMedGoogle Scholar
• Kirkwood J. M., Strawderman M. H., Ernstoff M. S. et al. Adjuvant therapy of high-risk resected melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol, 1996, 14: 7-17.
   PubMed Web of Science ®Google Scholar
• Pehamberger H., Soyer H. P., Steiner A. et al. Adjuvant Interferon Alfa-2a treatment in resected primary stage II cutaneous melanoma. J Clin Oncol, 1998, 16: 1425-9.
   PubMed Web of Science ®Google Scholar
• Lieber K. A., Standiford S. B., Kuvshinoff B. W., Ota D. M. Surgical management of aberrant sentinel lymph node drainage in cutaneous melanoma. Surgery, 1998, 124: 757-61.
   PubMed Web of Science ®Google Scholar
• Gershenwald J. E., Tseng C. H., Thompson W., Mansfield P. F., Lee J. E., Bouvet M., Lee J. J., Ross M. I. Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. Surgery, 1998, 124: 203-10.
   PubMed Web of Science ®Google Scholar
• Glass F. L., Cottam J. A., Reintgen D. S., Fenske N. A. Lymphatic mapping and sentinel node biopsy in the management of high-risk melanoma. J Am Acad Dermatol, 1998, 39: 603-10.
   PubMed Web of Science ®Google Scholar
• Joseph E., Brobeil A., Glass F. et al. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol, 1998, 5: 119-25.
   PubMed Web of Science ®Google Scholar
• Landi G., Polverelli M., Morelli R. The gamma probe guide for sentinel lymph node biopsy in melanoma staging. Abstract presented in: Frontiers in melanoma. Vienna, October 1-4, 1998.
   Google Scholar
• Schneebaum S., Briele H. A., Walker M. J. et al. Cutaneous thick melanoma: prognosis and treatment. Arch Surg, 1987, 122: 707-11.
   PubMedGoogle Scholar
• Gershenwald J. E., Colome M. I., Mansfield P. F., Tseng C. H., Lee J. J., Balch C. M., Ross M. I. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or 11 melanoma. J Clin Oncol, 1998, 16: 2253-60.
   PubMed Web of Science ®Google Scholar
• Wang X., Heller R., Van Voorhis N. et al. Detection of submicroscopic metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg. 1994, 220: 768-74.
   PubMed Web of Science ®Google Scholar
• Morton D. L. Sentinel lymphadenectomy for patients with clinical stage I melanoma. J Surg Oncol, 1997, 66: 267-9.
   PubMed Web of Science ®Google Scholar